BMP Pharma Trading (BMP) Stock Overview
Trades in raw materials for the pharmaceutical, dietary supplement, and veterinary industries. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
BMP Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
BMP Pharma Trading AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €6.30 |
| 52 Week High | €8.00 |
| 52 Week Low | €4.72 |
| Beta | 1.62 |
| 1 Month Change | -4.55% |
| 3 Month Change | 26.00% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 262.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| BMP | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -10.0% | -3.6% | -1.2% |
| 1Y | n/a | -2.5% | 0.5% |
Return vs Industry: Insufficient data to determine how BMP performed against the German Healthcare industry.
Return vs Market: Insufficient data to determine how BMP performed against the German Market.
Price Volatility
| BMP volatility | |
|---|---|
| BMP Average Weekly Movement | 19.8% |
| Healthcare Industry Average Movement | 5.2% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in DE Market | 12.8% |
| 10% least volatile stocks in DE Market | 2.8% |
Stable Share Price: BMP's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: BMP's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 54 | Henning Nau | www.bmp.ag |
BMP Pharma Trading AG trades in raw materials for the pharmaceutical, dietary supplement, and veterinary industries. It offers extracts, dietary supplements, cosmetics, narcotics, and human and veterinary active pharmaceutical ingredients (APIs). The company also offers pharmaceutical raw materials/active ingredients division supplies pharmaceutical active ingredients and raw materials for the veterinary industry to obtain and trade with and develops marketing strategies; nutritional supplements for the fitness, training and athletics industries with raw materials; pioneering the development of additives and premixes for animal feed; and medical cosmetic institutes exclusive products.
BMP Pharma Trading AG Fundamentals Summary
| BMP fundamental statistics | |
|---|---|
| Market cap | €33.08m |
| Earnings (TTM) | €2.48m |
| Revenue (TTM) | €2.31k |
Is BMP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BMP income statement (TTM) | |
|---|---|
| Revenue | €2.31k |
| Cost of Revenue | €1.79k |
| Gross Profit | €527.00 |
| Other Expenses | -€2.48m |
| Earnings | €2.48m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.47 |
| Gross Margin | 22.77% |
| Net Profit Margin | 107,186.60% |
| Debt/Equity Ratio | 0% |
How did BMP perform over the long term?
See historical performance and comparisonDividends
Does BMP pay a reliable dividends?
See BMP dividend history and benchmarks| BMP Pharma Trading dividend dates | |
|---|---|
| Ex Dividend Date | Jul 10 2026 |
| Dividend Pay Date | Jul 14 2026 |
| Days until Ex dividend | 6 days |
| Days until Dividend pay date | 2 days |
Does BMP pay a reliable dividends?
See BMP dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/14 19:11 |
| End of Day Share Price | 2026/07/14 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BMP Pharma Trading AG is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.